These factors activate NF-κB, p38MAPK, and JAK/STAT signaling pathways, leading to remodeling of the tumor microenvironment, characterized by an increase in immunosuppressive cells (Tregs, MDSCs) and enhanced angiogenesis (Gao et al., 2025). This evidence concerns the gene NFKB1 and neoplasm.